Functional Copy-Number Alterations as Diagnostic and Prognostic Biomarkers in Neuroendocrine Tumors
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25147532 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hayley Vaughn und 13 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Graduate Program in Genetics, University of Iowa, Iowa City, IA 52242, USA. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, DNA Copy Number Variations, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NCI NET SPORE grant.
Abstract (Originalsprache)
Functional copy-number alterations (fCNAs) are DNA copy-number changes with concordant differential gene expression. These are less likely to be bystander genetic lesions and could serve as robust and reproducible tumor biomarkers. To identify candidate fCNAs in neuroendocrine tumors (NETs), we integrated chromosomal microarray (CMA) and RNA-seq differential gene-expression data from 31 pancreatic (pNETs) and 33 small-bowel neuroendocrine tumors (sbNETs). Tumors were resected from 47 early-disease-progression (24 months) patients. Candidate fCNAs that accurately differentiated these groups in this discovery cohort were then replicated using fluorescence in situ hybridization (FISH) on formalin-fixed, paraffin-embedded (FFPE) tissues in a larger validation cohort of 60 pNETs and 82 sbNETs (52 early- and 65 late-disease-progression samples). Logistic regression analysis revealed the predictive ability of these biomarkers, as well as the assay-performance metrics of sensitivity, specificity, and area under the curve. Our results indicate that copy-number changes at chromosomal loci 4p16.3, 7q31.2, 9p21.3, 17q12, 18q21.2, and 19q12 may be used as diagnostic and prognostic NET biomarkers. This involves a rapid, cost-effective approach to determine the primary tumor site for patients with metastatic liver NETs and to guide risk-stratified therapeutic decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interdisciplinary Graduate Program in Genetics, University of Iowa, Iowa City, IA 52242, USA.
- Stead Family Department of Pediatrics, University of Iowa Health Care, Iowa City, IA 52242, USA.
- Department of Surgery, University of Iowa Health Care, Iowa City, IA 52242, USA.
- Department of Biomedical Engineering, University of Iowa, Iowa City, IA 52242, USA.
- Department of Pathology, University of Iowa, Iowa City, IA 52242, USA.
- Department of Biostatistics, University of Iowa, Iowa City, IA 52242, USA.
ORCID-Profile: Heather Major, Patrick Breheny, Dawn E Quelle, James R Howe
Förderung
- NCI NIH HHS
- NIH HHS
- NCI NET SPORE grant
- Interdisciplinary Genetics T32 Predoctoral Training Grant
- NCI R01 grant
- Stead Family Department of Pediatrics departmental funds
Zitieren
APA
Vaughn, H., Major, H., Kadera, E., Keck, K., Dunham, T., Qian, Q., Brown, B., Scott, A., Bellizzi, A. M., Braun, T., Breheny, P., Quelle, D. E., Howe, J. R., & Darbro, B. (2024). Functional Copy-Number Alterations as Diagnostic and Prognostic Biomarkers in Neuroendocrine Tumors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147532
Vancouver
Vaughn H, Major H, Kadera E, Keck K, Dunham T, Qian Q, et al. Functional Copy-Number Alterations as Diagnostic and Prognostic Biomarkers in Neuroendocrine Tumors. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147532
BibTeX
@article{Vaughn2024,
author = {Vaughn, Hayley and Major, Heather and Kadera, Evangeline and Keck, Kendall and Dunham, Timothy and Qian, Qining and Brown, Bartley and Scott, Aaron and Bellizzi, Andrew M and Braun, Terry and Breheny, Patrick and Quelle, Dawn E and Howe, James R and Darbro, Benjamin},
title = {Functional Copy-Number Alterations as Diagnostic and Prognostic Biomarkers in Neuroendocrine Tumors},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25147532}
}
EUVIMED